Alpha DNA Investment Management’s CrowdStrike CRWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-7,736
Closed -$741K 215
2024
Q2
$741K Sell
7,736
-2,164
-22% -$180K 0.29% 77
2024
Q1
$793K Buy
+9,900
New +$758K 0.29% 74
2023
Q2
Sell
-40,220
Closed -$1.38M 170
2023
Q1
$1.38M Buy
+40,220
New +$1.16M 0.41% 53
2022
Q4
Sell
-18,964
Closed -$781K 159
2022
Q3
$781K Sell
18,964
-6,996
-27% -$320K 0.65% 43
2022
Q2
$1.09M Buy
25,960
+624
+2% +$28.3K 0.93% 30
2022
Q1
$1.44M Sell
25,336
-10,980
-30% -$512K 1.01% 16
2021
Q4
$1.86M Buy
+36,316
New +$2.21M 1.17% 17
2021
Q3
Sell
-25,908
Closed -$1.63M 115
2021
Q2
$1.63M Buy
25,908
+25,328
+4,367% +$1.36M 1.11% 25
2021
Q1
$25K Buy
580
+120
+26% +$6.35K 0.03% 236
2020
Q4
$24K Buy
+460
New +$17.9K 0.03% 244

Other funds holding CRWD

Alpha DNA Investment Management's CRWD Position: Q3 2024 in Review

Alpha DNA Investment Management sold out of CrowdStrike (CRWD) in Q3 2024, closing a stake of 7,736 shares — an estimated $741K sold.

Alpha DNA Investment Management first reported a position in CRWD in Q4 2020 and held it in 10 quarters. The position peaked at $1.86M in Q4 2021. 1,584 funds tracked by Wall St. Rank hold CRWD as of Q3 2024.

  • Alpha DNA Investment Management reported no remaining CrowdStrike position as of Q3 2024 after selling out during the quarter.
  • Alpha DNA Investment Management sold 7,736 CrowdStrike shares in Q3 2024, an estimated $741K.
  • Alpha DNA Investment Management first reported a position in CrowdStrike in Q4 2020 and held it in 10 quarters.
  • Alpha DNA Investment Management's CrowdStrike position peaked at $1.86M in Q4 2021.
  • 1,584 funds tracked by Wall St. Rank held CrowdStrike as of Q3 2024.

Based on Alpha DNA Investment Management's 13F filing for Q3 2024, filed 12 Nov 2024.